The effect of SGLT2 inhibitor on renal anemia in patients with moderate to severe chronic kidney disease and diabetes
SGLT2 inhibitor therapy leads to a small but significant increase in hemoglobin level in patients with diabetes, including those with moderate to severe CKD.
Authors
- Gabriel Chan (ORCID: https://orcid.org/0000-0002-0997-1028)
- Kai-Ming Chow
- Chuanlei Li (ORCID: https://orcid.org/0000-0002-4460-7918)
- Cheuk‐Chun Szeto (ORCID: https://orcid.org/0000-0002-8898-8505)
- Jack KC Ng
- Winston Wing‐Shing Fung (ORCID: https://orcid.org/0000-0001-7676-7628)
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.5414/cn111700
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00